Results 191 to 200 of about 24,113 (230)
Some of the next articles are maybe not open access.
A Clinical Trial of FK506 in Refractory Uveitis
American Journal of Ophthalmology, 1993We performed a clinical open trial to evaluate the efficacy and the adverse side effects of a single therapy with FK506 in refractory uveitis as a multicenter study in Japan. Fifty-three patients (41 patients with Bechçet's disease, five with Vogt-Koyanagi-Harada disease, four with idiopathic retinal vasculitis, and three with other forms of uveitis ...
Manabu Mochizuki +12 more
openaire +2 more sources
The Effect Of Fk506 On Canine Bile Flow
Transplantation, 1993While the primary immunosuppressive agents utilized in solid-organ transplantation are steroids and cyclosporine, the more recently introduced agent FK506 is assuming a progressively more important role as an immunosuppressant, particularly in liver transplantation.
J C, Reese +4 more
openaire +2 more sources
Comparative efficacy of liposomal FK506 with FK506
Transplantation Proceedings, 1998S D, Moffatt +3 more
openaire +2 more sources
Overview of FK506 in transplantation.
Clinical transplants, 1991FK506 is a potent immunosuppressive agent which is undergoing clinical testing in liver, kidney, heart, and bone marrow transplantation. It has been shown to effectively prevent and reverse ongoing rejection in these models. From the outset, FK506 was used with low-dose steroids to treat 110 primary liver, 30 heart, and 66 kidney graft recipients ...
Fung, JJ +9 more
openaire +1 more source
Development of a macromolecular prodrug of FK506: I. synthesis of FK506-dextran conjugate
Transplantation Proceedings, 1998H, Yura +5 more
openaire +2 more sources
Stability of FK506 in Blood Samples
Therapeutic Drug Monitoring, 1996A M, Alak, P, Lizak
openaire +2 more sources
Atomic Structures of the Human Immunophilin FKBP-12 Complexes with FK506 and Rapamycin
Journal of Molecular Biology, 1993Robert F. Standaert +2 more
exaly
Delivery of FK506-loaded PLGA nanoparticles prolongs cardiac allograft survival
International Journal of Pharmaceutics, 2020Qing Lv, Mingxing Xie, Qiaofeng Jin
exaly
FK506, Artificial Intelligence and Pharmacoeconomics
The Journal of Clinical Pharmacology, 1993openaire +2 more sources

